中科院《国际期刊预警名单（试行）》名单
2023年01月发布的2023版：不在预警名单中
2021年12月发布的2021版：不在预警名单中
2021年01月发布的2020版：不在预警名单中
《国际期刊预警名单（试行）》2023版共计包含28本期刊（查看）
《国际期刊预警名单（试行）》2021版共计包含35本期刊（查看）
《国际期刊预警名单（试行）》2020版共计包含65本期刊（查看）
《Cancer Medicine》相关链接
PubMed Central (PMC)链接：
http://www.ncbi.nlm.nih.gov/nlmcatalog?term=%5BISSN%5D
平均审稿速度：
19 Weeks
平均录用比例：
123学术网预审服务：
经过123学术网预审的论文，能够提前知晓自己的论文稿件是否达到自己目标分区、分值的杂志社的录用标准，同时节约自己大量投稿时间，若预审通过，123学术网客服会进一步向您反馈预审结果，如果双方对预审结果达成一致，则需要与我方签订咨询服务协议，以协助您结合审稿人的审稿意见进一步优化稿件质量，以实现文章录用结果。
若预审不能通过，说明论文稿件质量无法达到杂志社的录用标准，可考虑123学术网润色服务，不仅能满足Cancer Medicine的语言要求，还能让Cancer Medicine编辑和审稿人得到更好的审稿体验，让稿件最大限度被Cancer Medicine编辑和审稿人充分理解和公正评估。
123学术网已助力全球10万+作者顺利发表论文。
《Cancer Medicine》期刊简介
Cancer Medicine is a peer-reviewed, open access, interdisciplinary journal providing rapid publication of research from global biomedical researchers across the cancer sciences. The journal will consider submissions from all oncologic specialties, including, but not limited to, the following areas:
Clinical Cancer Research
Translational research ∙ clinical trials ∙ chemotherapy ∙ radiation therapy ∙ surgical therapy ∙ clinical observations ∙ clinical guidelines ∙ genetic consultation ∙ ethical considerations
Cancer Biology:
Molecular biology ∙ cellular biology ∙ molecular genetics ∙ genomics ∙ immunology ∙ epigenetics ∙ metabolic studies ∙ proteomics ∙ cytopathology ∙ carcinogenesis ∙ drug discovery and delivery.
Cancer Prevention:
Behavioral science ∙ psychosocial studies ∙ screening ∙ nutrition ∙ epidemiology and prevention ∙ community outreach.
Bioinformatics:
Gene expressions profiles ∙ gene regulation networks ∙ genome bioinformatics ∙ pathwayanalysis ∙ prognostic biomarkers.
Cancer Medicine publishes original research articles, systematic reviews, meta-analyses, and research methods papers, along with invited editorials and commentaries. Original research papers must report well-conducted research with conclusions supported by the data presented in the paper.
